Pediatric Gastroenterology, Hepatology & Nutrition

  • 제23권6호
  • /
  • Pages.521-530
  • /
  • 2020
  • /
  • 2234-8646(pISSN)
  • /
  • 2234-8840(eISSN)
대한소아소화기영양학회 (The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition)
권호 표지
DOI QR코드

DOI QR Code

Management of Enteral Nutrition in the Pediatric Intensive Care Unit: Prokinetic Effects of Amoxicillin/Clavulanate in Real Life Conditions

  • Chiusolo, Fabrizio (Anesthesia and Critical Care Medicine, ARCO Rome, Bambino Gesu Children's Hospital, IRCCS) ;
  • Capriati, Teresa (Artificial Nutrition Unit, Bambino Gesiu Children's Hospital, IRCCS) ;
  • Erba, Ilaria (Anesthesia and Critical Care Medicine, ARCO Rome, Bambino Gesu Children's Hospital, IRCCS) ;
  • Bianchi, Roberto (Anesthesia and Critical Care Medicine, ARCO Rome, Bambino Gesu Children's Hospital, IRCCS) ;
  • Atti, Marta Luisa Ciofi degli (Department of Epidemiology and Statistical Analysis, Bambino Gesu Children's Hospital, IRCCS) ;
  • Picardo, Sergio (Anesthesia and Critical Care Medicine, ARCO Rome, Bambino Gesu Children's Hospital, IRCCS) ;
  • Diamanti, Antonella (Artificial Nutrition Unit, Bambino Gesiu Children's Hospital, IRCCS)
  • 투고 : 2020.03.17
  • 심사 : 2020.07.16
  • 발행 : 2020.11.15
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Purpose: Malnutrition is a common feature in critically ill children. Enteral nutrition (EN) is the main strategy to nutritionally support critical ill children, but its use can be hindered by the development of intolerance. The study aimed to assess the effectiveness and safety of amoxicillin/clavulanate (A/C) to treat EN intolerance. Methods: We retrospectively evaluated patients admitted to the pediatric intensive care unit from October 2018 to October 2019. We conducted a case-control study: in the first 6 months (October 2018-April 2019) we implemented the nutritional protocol of our Institution with no drug, whereas in the second half (May 2019-October 2019) we employed A/C for 1 week at a dose of 10 mg/kg twice daily. Results: Twelve cases were compared with 12 controls. At the final evaluation, enteral intake was significantly higher than that at baseline in the cases (from 2.1±3.7 to 66.1±27.4% of requirement, p=0.0001 by Wilcoxon matched-pairs signed rank test) but not in the controls (from 0.2±0.8 to 6.0±14.1% of the requirement, p=NS). Final gastric residual volume at the end of the observation was significantly lower in the cases than in the controls (p=0.0398). The drug was well tolerated as shown by the similar safety outcomes in both cases and controls. Conclusion: Malnutrition exposes critically ill children to several complications that affect the severity of disease course, length of stay, and mortality; all may be prevented by early EN. The development of intolerance to EN could be addressed with the use of A/C. Future prospective clinical trials are needed to confirm these conclusions.

키워드

참고문헌

  1. Mehta NM, Duggan CP. Nutritional deficiencies during critical illness. Pediatr Clin North Am 2009;56:1143-60. https://doi.org/10.1016/j.pcl.2009.06.007
  2. Kim H, Stotts NA, Froelicher ES, Engler MM, Porter C. Why patients in critical care do not receive adequate enteral nutrition? A review of the literature. J Crit Care 2012;27:702-13. https://doi.org/10.1016/j.jcrc.2012.07.019
  3. de Menezes FS, Leite HP, Nogueira PC. What are the factors that influence the attainment of satisfactory energy intake in pediatric intensive care unit patients receiving enteral or parenteral nutrition? Nutrition 2013;29:76-80. https://doi.org/10.1016/j.nut.2012.04.003
  4. Braegger C, Decsi T, Dias JA, Hartman C, Kolacek S, Koletzko B, et al. Practical approach to paediatric enteral nutrition: a comment by the ESPGHAN committee on nutrition. J Pediatr Gastroenterol Nutr 2010;51:110-22. https://doi.org/10.1097/MPG.0b013e3181d336d2
  5. Canarie MF, Barry S, Carroll CL, Hassinger A, Kandil S, Li S, et al. Risk factors for delayed enteral nutrition in critically ill children. Pediatr Crit Care Med 2015;16:e283-9. https://doi.org/10.1097/PCC.0000000000000527
  6. Meyer R, Harrison S, Sargent S, Ramnarayan P, Habibi P, Labadarios D. The impact of enteral feeding protocols on nutritional support in critically ill children. J Hum Nutr Diet 2009;22:428-36. https://doi.org/10.1111/j.1365-277X.2009.00994.x
  7. Tillman EM, Smetana KS, Bantu L, Buckley MG. Pharmacologic treatment for pediatric gastroparesis: a review of the literature. J Pediatr Pharmacol Ther 2016;21:120-32. https://doi.org/10.5863/1551-6776-21.2.120
  8. European Medicines Agency. European Medicines Agency recommends changes to the use of metoclopramide [Internet]. London: European Medicines Agency; 2013 Jul 26 [cited 2019 May 21]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2013/07/WC500146614.pdf
  9. Tomomasa T, Kuroume T, Arai H, Wakabayashi K, Itoh Z. Erythromycin induces migrating motor complex in human gastrointestinal tract. Dig Dis Sci 1986;31:157-61. https://doi.org/10.1007/BF01300701
  10. Caron F, Ducrotte P, Lerebours E, Colin R, Humbert G, Denis P. Effects of amoxicillin-clavulanate combination on the motility of the small intestine in human beings. Antimicrob Agents Chemother 1991;35:1085-8. https://doi.org/10.1128/AAC.35.6.1085
  11. Gomez R, Fernandez S, Aspirot A, Punati J, Skaggs B, Mousa H, et al. Effect of amoxicillin/clavulanate on gastrointestinal motility in children. J Pediatr Gastroenterol Nutr 2012;54:780-4. https://doi.org/10.1097/MPG.0b013e31824204e4
  12. Mehta NM, Skillman HE, Irving SY, Coss-Bu JA, Vermilyea S, Farrington EA, et al. Guidelines for the provision and assessment of nutrition support therapy in the pediatric critically ill patient: Society of Critical Care Medicine and American Society for Parenteral and Enteral Nutrition. Pediatr Crit Care Med 2017;18:675-715. https://doi.org/10.1097/PCC.0000000000001134
  13. Societa Italiana di Nutrizione Umana. Fabbisogno energetico medio (AR) nell'intervallo d'eta 6-12 mesi [Internet]. Milano: Societa Italiana di Nutrizione Umana; 2014 [cited 2014 Oct 20]. Available from: https://sinu.it/2019/07/09/fabbisogno-energetico-medio-ar-nellintervallo-deta-6-12-mesi/. Italian.
  14. Societa Italiana di Nutrizione Umana. Fabbisogno energetico medio (AR) nell'intervallo d'eta 1-17 anni [Internet]. Milano: Societa Italiana di Nutrizione Umana; 2014 [cited 2014 Oct 20]. Available from: https://sinu.it/2019/07/09/fabbisogno-energetico-medio-ar-nellintervallo-deta-1-17-anni/. Italian.
  15. Becker P, Carney LN, Corkins MR, Monczka J, Smith E, Smith SE, et al. Consensus statement of the Academy of Nutrition and Dietetics/American Society for Parenteral and Enteral Nutrition: indicators recommended for the identification and documentation of pediatric malnutrition (undernutrition). Nutr Clin Pract 2015;30:147-61. https://doi.org/10.1177/0884533614557642
  16. Fivez T, Kerklaan D, Mesotten D, Verbruggen S, Wouters PJ, Vanhorebeek I, et al. Early versus late parenteral nutrition in critically ill children. N Engl J Med 2016;374:1111-22. https://doi.org/10.1056/NEJMoa1514762
  17. Hauer J. Feeding intolerance in children with severe impairment of the central nervous system: strategies for treatment and prevention. Children (Basel) 2017;5:1. https://doi.org/10.3390/children5010001
  18. Thapar N, Saliakellis E, Benninga MA, Borrelli O, Curry J, Faure C, et al. Paediatric intestinal pseudoobstruction: evidence and consensus-based recommendations from an ESPGHAN-led expert group. J Pediatr Gastroenterol Nutr 2018;66:991-1019. https://doi.org/10.1097/MPG.0000000000001982
  19. Romano C, van Wynckel M, Hulst J, Broekaert I, Bronsky J, Dall'Oglio L, et al. European Society for Paediatric Gastroenterology, Hepatology and Nutrition guidelines for the evaluation and treatment of gastrointestinal and nutritional complications in children with neurological impairment. J Pediatr Gastroenterol Nutr 2017;65:242-64. https://doi.org/10.1097/MPG.0000000000001646
  20. Mehta NM, Corkins MR, Lyman B, Malone A, Goday PS, Carney LN, et al. Defining pediatric malnutrition: a paradigm shift toward etiology-related definitions. JPEN J Parenter Enteral Nutr 2013;37:460-81. https://doi.org/10.1177/0148607113479972
  21. World Health Organization. The Treatment of diarrhoea: a manual for physicians and other senior health workers [Internet]. Geneva: World Health Organization; 2005 [cited 2020 Mar 10]. Available from: http://whqlibdoc.who.int/publications/2005/9241593180.pdf
  22. Manini ML, Camilleri M, Grothe R, Di Lorenzo C. Application of pyridostigmine in pediatric gastrointestinal motility disorders: a case series. Paediatr Drugs 2018;20:173-80. https://doi.org/10.1007/s40272-017-0277-6
  23. Ericson JE, Arnold C, Cheeseman J, Cho J, Kaneko S, Wilson E, et al. Use and safety of erythromycin and metoclopramide in hospitalized infants. J Pediatr Gastroenterol Nutr 2015;61:334-9. https://doi.org/10.1097/MPG.0000000000000792
  24. Lake JG, Weiner LM, Milstone AM, Saiman L, Magill SS, See I. Pathogen distribution and antimicrobial resistance among pediatric healthcare-associated infections reported to the National Healthcare Safety Network, 2011-2014. Infect Control Hosp Epidemiol 2018;39:1-11. https://doi.org/10.1017/ice.2017.236